Researchers develop new test to target prostate cancer treatment
admin 19th June 2017 Uncategorised 0UK-based scientists have developed a new three-in-one blood test able to identify the patients with advanced prostate cancer most likely to benefit from PARP inhibitors, with the potential to ‘transform’ treatment of the disease.
More: Researchers develop new test to target prostate cancer treatment
Source: News